IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
about
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn DiseaseRegulation of lung immunity and host defense by the intestinal microbiotaInflammatory pathways of importance for management of inflammatory bowel diseaseEndoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseasesInteractions between the microbiota and the immune systemPIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signalingCombined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility lociThe IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humansInflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidencesCrohn disease: a current perspective on genetics, autophagy and immunityHost and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts.Polymorphisms of IL23R and Fuchs' syndrome in a Chinese Han population.Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis.Animal models of colitis-associated carcinogenesis.Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease.Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses.CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling.Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice.MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.Spontaneous and transgenic rodent models of inflammatory bowel diseasePersistent hyperglycemia modulates gut immune function and microbiota in rats.The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II miceDeletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice.Sirtuin 1 is a key regulator of the interleukin-12 p70/interleukin-23 balance in human dendritic cells.MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient miceVariations in IL-23 and IL-25 receptor gene structure, sequence and expression associated with the two disease forms of sheep paratuberculosismiR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.Common risk alleles for inflammatory diseases are targets of recent positive selectionElevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis.Expression of the novel adipokine C1qTNF-related protein 4 (CTRP4) suppresses colitis and colitis-associated colorectal cancer in mice.Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population.Pathogenic IL-23 signaling is required to initiate GM-CSF-driven autoimmune myocarditis in mice.Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harmA novel pathway by which the environmental toxin 4-Nonylphenol may promote an inflammatory response in inflammatory bowel disease.Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway.Using metabolomic analysis to understand inflammatory bowel diseases.Cytokine blockade in inflammatory bowel diseases.Direct and indirect regulatory mechanisms in TH17 cell differentiation and functions.The price of immunity.
P2860
Q24644398-10244596-428D-4914-83A9-722D8FBBF78DQ26779232-D121A287-1856-45CC-91B7-8A0A0AF65C71Q27005445-0F52EB43-F4A2-438C-9722-E4905EF2997BQ27027733-71660402-FFE7-4776-8548-8A3DEF2CF31DQ27028155-5BA91B32-64D6-43D1-B62C-44D1157B1178Q28833590-47F09A7A-7730-4A4C-8DFA-27986AD47763Q28924378-6F97154E-02AF-4099-9B9F-BB20AAAF52F6Q33833964-EB2A65B9-29E4-4DF7-8327-639580C28418Q34131254-92A92C96-D674-4157-B58B-9D0FCE347201Q34132601-08AB84D9-4CBC-4AE0-A008-C7B72037FE8BQ34164041-7CD57ABF-E896-443F-B30C-4DE01EED0C2CQ34396848-676C76F5-2BB5-4A51-927F-1E7CA13B1EFCQ34482747-6F8B7830-C963-47AD-BAD2-4C9C329A5B5CQ34512820-4AD880FA-985B-4794-B7E1-327166DFE489Q34601368-167F6938-41B6-4346-9C7A-1A241AD2176DQ34637606-7C7AC528-B098-423A-A003-FBC3417E059AQ35034902-09036C01-7F5B-454B-A0B9-26500846B8DBQ35475346-7DFEB03F-DE5D-4C69-90DC-3D7727081463Q35611022-12B30F68-0896-44B3-AEB8-3FF6EB5F9A57Q35745717-19E54554-35CC-4FE3-A95C-6892571FF26CQ35812593-32522CA2-BEFC-45A0-8E03-22B9F5032108Q35881062-FA60497F-E0B6-4CCE-B21E-77463D621C77Q36153059-71A89675-5B5F-416D-9D1E-5AAE52CCF3B2Q36179395-D8B04A63-F663-4628-917E-9CC4DF677FABQ36318922-08C8690A-27AA-4E0A-90FE-6DED1D4CA762Q36464520-2EEB500A-0B69-4CEB-B81D-73080FFEE6CFQ36565754-D353E5D7-3EFA-4462-9A79-F31C8B103AF6Q36733168-E53DF60E-591A-4A92-BAA4-67E34DE99632Q36742533-A11CDA35-BF77-4CFF-B56A-7C07D2466AF2Q37183121-C5403BE5-9111-4A68-B1E6-6D467018247EQ37285021-F1C5E3EA-234B-47DE-82D9-18E03077A6B3Q37457176-3950CFD2-68F6-442A-AB64-5969E7A3B8AAQ37498070-04AA3EAD-34A5-430D-9479-5DBA702E3197Q37576442-3277B3EE-0B5A-46C5-A9DC-08D4C9425F7BQ37719290-814CD8AF-7064-4123-BFB6-FCDE6DA7A031Q37745452-06A73224-5A9B-448C-A528-DE6902FE5D89Q37772447-04D636F1-0868-44C5-B987-E9E39421859AQ37952792-735FF771-3E66-4992-ACDD-311B6D585254Q37977126-C79FA536-9BBB-49F3-897B-B1A716A7234CQ38044667-AA4E4B1C-8C46-4A19-ADE3-4162A1F2F365
P2860
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
@en
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
@nl
type
label
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
@en
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
@nl
prefLabel
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
@en
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
@nl
P921
P1476
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
@en
P2093
Clara Abraham
Judy H Cho
P304
P356
10.1146/ANNUREV.MED.60.051407.123757
P577
2009-01-01T00:00:00Z